ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM (IBRX)

🌐 Seeking Alpha — 2026-05-19

ImmunityBio is exploring opportunities beyond bladder cancer, targeting a potentially multibillion-dollar market for solid tumors. This strategic shift may position the company strongly in the oncology sector.

Markets Deals Health ImmunityBio oncology bladder cancer solid tumor market opportunity

Read original source →

GCC states continue to consolidate their position as global economic, development power
Times of Oman — 2026-05-24
Why India can’t escape a global oil shock
Economic Times India — 2026-05-24
With oil markets nearing the danger zone, a US-Iran deal can’t come soon enough | Heather Stewart
The Guardian — 2026-05-24
Starting June 2026, trading hours extended for Muscat Stock Exchange
Times of Oman — 2026-05-24
India, US looking at firming up trade pact soon
Economic Times India — 2026-05-24
Iran war could add billions of dollars in interest payments to US debt
Financial Times — 2026-05-24

ImmunityBio: Looking Beyond Bladder Cancer To A Multibillion-Dollar Solid Tumor TAM (IBRX)

AI Summary

Related Articles

GCC states continue to consolidate their position as global economic, development power

Why India can’t escape a global oil shock

With oil markets nearing the danger zone, a US-Iran deal can’t come soon enough | Heather Stewart

Starting June 2026, trading hours extended for Muscat Stock Exchange

India, US looking at firming up trade pact soon

Iran war could add billions of dollars in interest payments to US debt